PROGNOSTIC-SIGNIFICANCE OF FLOW-CYTOMETRY STUDIES IN B-CELL NON-HODGKIN-LYMPHOMA

被引:49
|
作者
REHN, S
GLIMELIUS, B
STRANG, P
SUNDSTROM, C
TRIBUKAIT, B
机构
[1] KAROLINSKA INST, DEPT MED RADIOBIOL, S-10401 STOCKHOLM 60, SWEDEN
[2] UNIV UPPSALA, AKAD SJUKHUSET, DEPT PATHOL, S-75185 UPPSALA, SWEDEN
关键词
DNA‐measurement; Flow cytometry; Non‐Hodgkin lymphoma; Prognosis; S‐phase rate;
D O I
10.1002/hon.2900080102
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic relevance of flow cytometric DNA measurements of lymph node biopsies in relation to histopathology according to the Kiel classification, stage, age and presence or absence of B‐symptoms was investigated in 106 patients with non‐Hodgkin lymphomas (NHL) of proven B‐cell type. Biopsies were taken at diagnosis before treatment. The mean proportion of cells in S‐phase was significantly lower in the 76 patients with a ‘low grade’ NHL (4.4 per cent) than in the 30 patients with a ‘high grade’ NHL (13.0 per cent) (p<0.0001). High S‐phase rates were associated with a poor prognosis within the whole material (p<0.01) and within the group of ‘high grade’ NHL (p<0.05). In the subgroup CB‐CC lymphomas of ‘low grade’ NHL, the prognostic value of the S‐phase rate was stronger than any other investigated parameter (p<0.05). In multivariate analyses, the S‐phase rate gave, in several subgroups, independent prognostic information, besides clinico‐pathological variables. Copyright © 1990 John Wiley & Sons, Ltd
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [21] THE PROGNOSTIC-SIGNIFICANCE OF THE DNA CONTENT OF BREAST-CANCER MEASURED BY FLOW-CYTOMETRY
    DOWLE, CS
    BURNS, K
    ROBINS, A
    OWAINATI, A
    ELLIS, IO
    BLAMEY, RW
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (01) : 106 - 106
  • [22] Prognostic significance of extranodal involvement in B-cell non-Hodgkin's lymphoma (NHL).
    Reiser, M
    Skavron, R
    Elter, T
    Pfistner, B
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 263B - 263B
  • [23] PROGNOSTIC-SIGNIFICANCE OF CLINICAL AND PATHOLOGICAL FEATURES IN DIFFUSE LARGE B-CELL LYMPHOMA
    NAKAMINE, H
    BAGIN, RG
    VOSE, JM
    BAST, MA
    BIERMAN, PJ
    ARMITAGE, JO
    WEISENBURGER, DD
    CANCER, 1993, 71 (10) : 3130 - 3137
  • [24] Low sensitivity of flow cytometry in bone marrow staging of B-cell non-Hodgkin lymphoma
    Polprasert, C.
    Srisakham, J.
    Asanasen, T.
    Nakorn, T. Na
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2007, 72B (02) : 137 - 138
  • [26] PROGNOSTIC-SIGNIFICANCE OF FLOW-CYTOMETRY IN LUNG-CANCER - A 5-YEAR STUDY
    TIRINDELLIDANESI, D
    TEODORI, L
    MAURO, F
    MODINI, C
    BOTTI, C
    CICCONETTI, F
    STIPA, S
    CANCER, 1987, 60 (04) : 844 - 851
  • [28] 2 B-CELL SUBPOPULATIONS IDENTIFIED BY FLOW-CYTOMETRY
    WATKINS, JR
    LOKEN, MR
    KNIGHT, KL
    IMMUNOLOGY, 1985, 56 (02) : 315 - 320
  • [29] SURFACE MARKER PHENOTYPIC VARIABLES OF PROGNOSTIC-SIGNIFICANCE IN B-CELL DERIVED NON-HODGKINS LYMPHOMA (NHL)
    RUDDERS, RA
    AHL, ET
    DELELLIS, RA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 224 - 224
  • [30] Immunophenotypic variability of B-cell non-Hodgkin lymphoma - A retrospective study of cases analyzed by flow cytometry
    Echeverri, C
    Fisher, S
    King, D
    Craig, FE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 117 (04) : 615 - 620